In the article titled “A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, randomized, Placebo-Controlled Study” [1], the dosage of drugs in the Materials and Methods and Results was given incorrectly as (250 mg x 1)/ day. It should be corrected to (250 mg x 2)/ day.
Corrigendum | Open Access
Corrigendum to “A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, randomized, Placebo-Controlled Study”
Received09 Jan 2019
Accepted28 Jan 2019
Published03 Mar 2019
References
N. T. Krishnareddy, J. V. Thomas, S. S. Nair, J. N. Mulakal, B. P. Maliakel, and I. M. Krishnakumar, “A novel curcumin-galactomannoside complex delivery system improves hepatic function markers in chronic alcoholics: A double-blinded, randomized, placebo-controlled study,” BioMed Research International, vol. 2018, Article ID 9159281, 10 pages, 2018.
View at: Publisher Site | Google Scholar
Copyright
Copyright © 2019 Naveen T. Krishnareddy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.